Laparoscopic Instruments Market by Product (Laparoscope, Insufflator, Suction/Irrigation systems, Access & Energy Devices), Application (Gynecology, General, Urology, Colorectal, Bariatric, Pediatric), End User (Hospital, ASC) - Global Forecast to 2026
Updated on : March 14, 2023
The global laparoscopic instruments market in terms of revenue was estimated to be worth $12.3 billion in 2021 and is poised to reach $22.1 billion by 2026, growing at a CAGR of 12.5% from 2021 to 2026. Market growth can largely be attributed to factors such as the increasing adoption of minimally invasive surgeries over open surgeries, rising prevalence of colorectal cancer, increasing number of laparoscopic bariatric procedures, and technological advancements in the field of laparoscopy. Growing healthcare markets in emerging economies and enhancements in equipment capabilities in laparoscopic instruments are expected to offer significant growth opportunities for market players.
To know about the assumptions considered for the study, download the pdf brochure
Laparoscopic Instruments Market Dynamics
Drivers: Increasing adoption of minimally invasive surgeries over open surgeries
Laparoscopic procedures are less invasive and save costs in terms of pre- and post-operation care and the length of stay in hospitals. These surgeries result in less blood loss, fewer postoperative complications, and a shorter recovery time for patients. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. These factors have led to an increased preference for minimally invasive surgeries among patients. Around 15 million laparoscopic procedures are performed annually worldwide, and this number is estimated to grow significantly in the coming years. Laparoscopic colectomy, laparoscopic appendectomy, laparoscopic cholecystectomy, laparoscopic repair of inguinal hernia, laparoscopic hysterectomy, and laparoscopic bariatric surgeries holds a major share (approximately 40–45%) in the surgical procedures market.
Restraints: Reduced Medicare payents to healthcare providers in the US
In August 2012, the US government planned to reduce Medicare spending by USD 716 billion over the next ten years (till 2022). As a part of its healthcare reform, a 2% cut in Medicare payments was announced for Critical Access Hospitals (CAH) and Cancer Hospital interim payments (effective from April 2013). Furthermore, the government imposed a 2.3% excise duty on the domestic sales of taxable medical devices, effective from 2013 (under the Patient Protection and Affordable Care Act, 2010). Industry stakeholders estimate these reforms to negatively affect the cash flow for medical device companies operating in the US. This reduced Medicare spending is likely to impact the reimbursements for medical procedures. Laparoscopic procedures have seen a slight increase in medical reimbursements, but considering the overall advantages offered by MIS, this is not sufficient and is not in proportion to the increasing healthcare spending. Moreover, from federal and commercial payers, laparoscopic procedures receive less reimbursement as compared to open surgical procedures. This will make it increasingly difficult for medical device manufacturers to secure investments for developing new products and will also affect the sales of their technologically advanced laparos
Opportunities: Growing healthcare markets in emerging economies
The healthcare industry in emerging markets is growing rapidly. Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. This can be attributed to the increasing public and private initiatives undertaken by market stakeholders across these countries, low regulatory barriers for trade, continuous improvements in healthcare infrastructure, growing patient population, rising healthcare expenditure, strengthening distribution networks of market leaders, and the rising medical tourism in these countries. The availability of high-quality surgical treatments at lower costs than developed markets has attracted many medical tourists. Currently, several laparoscopy equipment manufacturers are setting up their facilities in the Asia Pacific, the Middle East, and Latin America. Key players such as Stryker and KARL STORZ have already set up their manufacturing and R&D facilities in these countries. Also, the saturated matured markets in developed regions such as North America and Europe will further compel laparoscopic instruments manufacturers to focus on emerging markets in the coming years.
Challenges: Gaps in infrastructure support for laparoscopic procedures in developing countries
Access to basic surgical procedures is a major challenge faced by developing countries. Countries such as India, South Korea, and Singapore are making efforts to improve their infrastructure by increasing the number of hospitals and training centers for providing continuing medical education in fields such as laparoscopic surgeries. However, there remains a wide gap in the infrastructure available in these developing countries to support advanced medical procedures, such as laparoscopy. Developing countries face the challenge of bridging the gap in terms of infrastructural support available for performing laparoscopic procedures. For instance, as many as 5 billion people, or two-thirds of the world’s population, lack access to surgical facilities (Source: Global Surgery 2030: Evidence and Solutions for Achieving Health, Welfare, and Economic Development, The Lancet Commission, 2015). Around 143 million additional surgical procedures are needed in low-income and middle-income countries (LMICs) each year to save lives and prevent disabilities. The largest number of patients lacking access to surgeries live in South Asia (57.8 million), East Asia (27.9 million), and southern sub-Saharan Africa (18.9 million). The health systems in developing countries are struggling to provide the infrastructure and resources to support advanced surgical techniques such as laparoscopic procedures. This restricts the number of laparoscopic procedures performed in these countries and poses a challenge for the market.
North America is expected to account for the largest share of the laparoscopic instruments market in 2020
In 2020, North America accounted for the largest share of the global market. The US accounted for the largest share of the North American market. The large share of North America in the global market can be attributed to the growth in the geriatric and chronically ill population, increasing number of minimally invasive surgeries, and technological advancements.
Some of the major players in the Laparoscopic Instruments market include Intuitive Surgical, Inc. (US), Stryker Corporation (US), Olympus Corporation (Japan), Karl Storz GmbH & CO. KG (Germany), Medtronic PLC (Ireland), Microline Surgical, Inc. (US), B. Braun Melsungen AG (Germany), SCHÖLLY Fiberoptic GmbH (Germany), Optomic (Spain), Victor Medical Instruments Co., Ltd (China), Peters Surgical (France), EndoMed Systems GmbH (Germany), Becton, Dickinson and Company (US), Mindray Medical International Limited (China), CONMED Corporation (US), Richard Wolf GmbH (Germany), Smith & Nephew PLC (UK), Cook Medical (US), Ethicon (US), Strauss Surgical (US), AMNOTEC International Medical (Germany).
Laparoscopic Instruments Market Report Scope
|
Report Metric |
Details |
|
Market size available for years |
2019–2026 |
|
Base year considered |
2020 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
By Product, Application Type, End User |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa |
|
Companies covered |
Intuitive Surgical (US), Stryker Corporation (US), Olympus Corporation (Japan), Karl Storz GmbH & CO. KG (Germany), Medtronic PLC (Ireland), Microline Surgical, Inc. (US), B. Braun Melsungen AG (Germany), SCHÖLLY Fiberoptic GmbH (Germany), Optomic (Spain), Victor Medical Instruments Co., Ltd (China), Peters Surgical (France), EndoMed Systems GmbH (Germany), Becton, Dickinson and Company (US), Mindray Medical International Limited (China), CONMED Corporation (US), Richard Wolf GmbH (Germany), Smith & Nephew PLC (UK), Cook Medical (US), Ethicon (US), Strauss Surgical (US), AMNOTEC International Medical (Germany) |
The study categorizes the laparoscopic instruments market into following segments & sub-segments:
By Product Type
- Medical Laparoscopic Robots
- Laparoscopes
- Video Laparoscopes
- Fiber Laparosccpes
- Energy Devices
- Hand Instruments
- Closure Devices
- Access Devices
- Accessories
- Insufflators
- Suction/Irrigation Pumps
By Application Type
- General Surgery
- Gynecological Surgery
- Colorectal Surgery
- Bariatric Surgery
- Urological Surgery
- Pediatric Surgery;
By End User
- Hospitals
- Ambulatory Surgical Centers
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Rest of APAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2021, Olympus Corporation (Japan) launched the SIF-H190 single-balloon enteroscopy solution to reach deep into the small intestine
- In 2019, Intuitive Surgical, Inc. (US) received clearance from the US FDA for the da Vinc X Surgical System.
- In 2018, Stryker Corporation (US) Acquired K2M Group to strengthen and expand its offerings in the arthroscopy and minimally invasive spine portfolio, as well as expand its additive manufacturing capabilities
- In 2017, Ethicon (US) acquired Megadyne Medical (US) to bring together Ethicon’s advanced energy devices with Megadyne’s innovative portfolio of electrosurgical tools
Frequently Asked Questions (FAQ):
What is the projected market value of the global laparoscopic instruments market?
The global market of laparoscopic instruments is projected to reach USD 22.1 billion.
What is the estimated growth rate (CAGR) of the global laparoscopic instruments market for the next five years?
The global laparoscopic instruments market is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.5% from 2021 to 2026.
What are the major revenue pockets in the laparoscopic instruments market currently?
In 2020, North America accounted for the largest share of the global market. The US accounted for the largest share of the North American laparoscopic instruments market. The large share of North America in the global laparoscopic instruments market can be attributed to the growth in the geriatric and chronically ill population, increasing number of minimally invasive surgeries, and technological advancements.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
FIGURE 7 REVENUE ANALYSIS OF THE TOP 5 COMPANIES: LAPAROSCOPIC INSTRUMENTS MARKET (2020)
FIGURE 8 DEMAND-SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MARKET (2021–2026)
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MARKET
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 13 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 14 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE MARKET
3 EXECUTIVE SUMMARY (Page No. - 53)
FIGURE 15 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2021 VS. 2026
FIGURE 16 MARKET, BY APPLICATION, 2021 VS. 2026
FIGURE 17 MARKET, BY END USER, 2021 VS. 2026
FIGURE 18 GEOGRAPHIC SNAPSHOT: MARKET
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 LAPAROSCOPIC INSTRUMENTS MARKET OVERVIEW
FIGURE 19 INCREASED ADOPTION OF MINIMALLY INVASIVE SURGERIES OVER OPEN SURGERIES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: MARKET, BY APPLICATION
FIGURE 20 GENERAL SURGERY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC MARKET
4.3 MARKET: GEOGRAPHIC MIX
FIGURE 21 US TO WITNESS THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 LAPAROSCOPIC INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing adoption of minimally invasive surgeries over open surgeries
5.2.1.2 Rising prevalence of colorectal cancer
FIGURE 23 GROWTH ESTIMATES FOR THE NUMBER OF NEW COLORECTAL CANCER CASES ACROSS THE GLOBE, 2020–2040
5.2.1.3 Increasing number of laparoscopic bariatric procedures
FIGURE 24 US: GROWTH IN THE NUMBER OF BARIATRIC SURGERIES, 2011–2018
TABLE 2 NUMBER OF BARIATRIC SURGERIES PERFORMED WORLDWIDE IN 2018
5.2.1.4 Technological advancements in the field of laparoscopy
TABLE 3 TECHNOLOGICAL ADVANCEMENTS IN LAPAROSCOPIC INSTRUMENTS
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reduced Medicare payments to healthcare providers in the US
TABLE 4 MEDICARE PAYMENTS FOR LAPAROSCOPIC PROCEDURES, 2015 VS. 2020
5.2.2.2 Dearth of trained professionals in the field of laparoscopy
TABLE 5 US: TOTAL NUMBER OF SURGEONS (2010–2017)
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Growing healthcare markets in emerging economies
5.2.3.2 Enhancements in the capabilities of laparoscopic instruments
5.2.4 MARKET CHALLENGES
5.2.4.1 Product recalls
TABLE 6 LIST OF PRODUCT RECALLS
5.2.4.2 Gaps in infrastructural support for laparoscopic procedures in developing countries
5.3 NUMBER OF LAPAROSCOPIC PROCEDURES
5.3.1 NUMBER OF LAPAROSCOPIC COLECTOMY PROCEDURES, BY COUNTRY/REGION, 2014–2018
5.3.2 NUMBER OF LAPAROSCOPIC APPENDECTOMY PROCEDURES, BY COUNTRY/REGION, 2014–2018
5.3.3 NUMBER OF LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES, BY COUNTRY/REGION, 2014–2018
5.3.4 NUMBER OF LAPAROSCOPIC INGUINAL HERNIA REPAIR PROCEDURES, BY COUNTRY/REGION, 2014–2018
5.3.5 NUMBER OF LAPAROSCOPIC HYSTERECTOMY PROCEDURES, BY COUNTRY/REGION, 2014–2018
5.4 PRICING ANALYSIS
FIGURE 25 AVERAGE SELLING PRICE CONTRIBUTION OF VARIOUS COMPONENTS IN A FLEXIBLE LAPAROSCOPE
FIGURE 26 AVERAGE SELLING PRICE CONTRIBUTION OF VARIOUS COMPONENTS IN A RIGID LAPAROSCOPE
TABLE 7 VARIOUS SPECIFICATIONS FOR LAPAROSCOPES
TABLE 8 AVERAGE SELLING PRICE OF LAPAROSCOPES
5.5 VALUE CHAIN ANALYSIS
FIGURE 27 MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 28 MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 MARKET: SUPPLY CHAIN ANALYSIS
5.9 IMPACT OF COVID-19 ON THE MARKET
5.10 REGULATORY ANALYSIS
5.10.1 NORTH AMERICA
5.10.1.1 US
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.10.1.2 Canada
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 30 CANADA: CLASS II MEDICAL DEVICES APPROVAL PROCESS
5.10.2 EUROPE
FIGURE 31 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 Japan
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.10.3.2 China
TABLE 14 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.10.3.3 India
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR LAPAROSCOPES
FIGURE 32 PATENT PUBLICATION TRENDS (2015–2020)
5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR LAPAROSCOPE PATENTS
FIGURE 33 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR LAPAROSCOPE PATENTS (2015–2021)
5.11.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR LAPAROSCOPE PATENTS
FIGURE 34 TOP APPLICANT COUNTRIES FOR LAPAROSCOPE PATENTS (2015–2021)
5.12 TECHNOLOGICAL ANALYSIS
5.12.1 KEY TECHNOLOGY
5.12.1.1 Application of vision systems
5.12.1.2 Complementary technology
5.12.1.2.1 Robot-assisted surgeries
5.12.1.3 Adjacent technology
5.12.1.3.1 Haptic and sensory feedback
5.13 TREND ANALYSIS
TABLE 16 SOME OF THE IMPORT/EXPORT TRADES RELATED TO LAPAROSCOPES
6 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT (Page No. - 88)
6.1 INTRODUCTION
TABLE 17 MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 MEDICAL LAPAROSCOPIC ROBOTS
6.2.1 MEDICAL ROBOTS ACCOUNTED FOR THE LARGEST SHARE IN THE MARKET IN 2020
TABLE 18 MEDICAL LAPAROSCOPIC ROBOTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 LAPAROSCOPES
TABLE 19 LAPAROSCOPES AVAILABLE IN THE MARKET
FIGURE 35 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 20 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 21 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (THOUSAND UNITS)
TABLE 22 LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 23 LAPAROSCOPES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS)
6.3.1 VIDEO LAPAROSCOPES
6.3.1.1 Video laparoscopes dominate the laparoscopes market
TABLE 24 VIDEO LAPAROSCOPES AVAILABLE IN THE MARKET
TABLE 25 VIDEO LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 26 VIDEO LAPAROSCOPES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS)
6.3.2 FIBER LAPAROSCOPES
6.3.2.1 High-definition imaging capabilities drive the growth of the fiber laparoscopes market
TABLE 27 LAPAROSCOPES AVAILABLE IN THE MARKET
TABLE 28 FIBER LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 29 FIBER LAPAROSCOPES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS)
6.4 ENERGY DEVICES
6.4.1 INCREASING DEMAND FOR REUSABLE MONOPOLAR AND BIPOLAR COAGULATION ENERGY DEVICES DRIVES THE MARKET GROWTH
TABLE 30 ENERGY DEVICES AVAILABLE IN THE MARKET
TABLE 31 ENERGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.5 CLOSURE DEVICES
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN CLOSURE DEVICES DRIVES MARKET GROWTH
TABLE 32 CLOSURE DEVICES AVAILABLE IN THE MARKET
TABLE 33 CLOSURE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.6 HAND INSTRUMENTS
6.6.1 INCREASING NUMBER OF GENERAL LAPAROSCOPIC SURGERIES DRIVE THE GROWTH OF HAND INSTRUMENTS
TABLE 34 HAND INSTRUMENTS AVAILABLE IN THE MARKET
TABLE 35 HAND INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.7 ACCESS DEVICES
6.7.1 ACCESS DEVICES ARE REQUIRED TO CREATE AND MAINTAIN PORTS OF ENTRANCE FOR OTHER INSTRUMENTS
TABLE 36 ACCESS DEVICES AVAILABLE IN THE MARKET
TABLE 37 ACCESS DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.8 ACCESSORIES
6.8.1 INCREASING SURGICAL VOLUMES DRIVE DEMAND FOR ACCESSORIES
TABLE 38 LAPAROSCOPIC ACCESSORIES & THEIR FUNCTIONALITIES
TABLE 39 LAPAROSCOPIC ACCESSORIES AVAILABLE IN THE MARKET
TABLE 40 LAPAROSCOPIC ACCESSORIES MARKET, BY COUNTRY, 2019–20206 (USD MILLION)
6.9 INSUFFLATORS
6.9.1 RISING NUMBER OF LAPAROSCOPIC SURGERIES PERFORMED BOOSTS THE MARKET FOR CO2 INSUFFLATORS
TABLE 41 INSUFFLATORS AVAILABLE IN THE MARKET
TABLE 42 INSUFFLATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 43 INSUFFLATORS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS)
6.10 SUCTION/IRRIGATION SYSTEMS
6.10.1 GROWING TREND TOWARD INTEGRATED FLUID MANAGEMENT SYSTEMS FOR LAPAROSCOPIC PROCEDURES DRIVES THE MARKET GROWTH
TABLE 44 SUCTION/IRRIGATION SYSTEMS AVAILABLE IN THE MARKET
TABLE 45 SUCTION/IRRIGATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION (Page No. - 111)
7.1 INTRODUCTION
TABLE 46 MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 GENERAL SURGERY
7.2.1 PREFERENCE FOR LAPAROSCOPY TECHNIQUES IS INCREASING IN APPENDECTOMY, CHOLECYSTECTOMY, AND HERNIA REPAIR
TABLE 47 EVOLUTION OF LAPAROSCOPY FOR COMMON PROCEDURES IN GENERAL SURGERY
TABLE 48 LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2018
TABLE 49 LAPAROSCOPIC INGUINAL HERNIA REPAIR AND APPENDECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2013 VS. 2018
TABLE 50 MARKET FOR GENERAL SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 GYNECOLOGICAL SURGERY
7.3.1 THE NUMBER OF LAPAROSCOPIC HYSTERECTOMIES HAS INCREASED IN RECENT YEARS
TABLE 51 LAPAROSCOPIC HYSTERECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2013 VS. 2018
TABLE 52 MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 COLORECTAL SURGERY
7.4.1 INCREASING INCIDENCE OF COLORECTAL CANCER ACROSS THE GLOBE TO DRIVE MARKET GROWTH
TABLE 53 ESTIMATED NUMBER OF NEW CASES OF COLON, RECTAL, AND ANAL CANCER, BY REGION, 2020 VS. 2040 (THOUSAND)
TABLE 54 MARKET FOR COLORECTAL SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 BARIATRIC SURGERY
7.5.1 ADVANCEMENTS IN LAPAROSCOPIC TECHNIQUES TO IMPROVE BARIATRIC SURGICAL OUTCOMES TO DRIVE MARKET GROWTH
FIGURE 36 GROWTH IN THE NUMBER OF LAPAROSCOPIC SLEEVE GASTRECTOMY SURGICAL PROCEDURES IN THE US, 2011–2019
TABLE 55 MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 UROLOGICAL SURGERY
7.6.1 INCREASING INCIDENCE OF UROLOGICAL DISEASES TO DRIVE MARKET GROWTH
TABLE 56 MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
7.7 PEDIATRIC SURGERY
7.7.1 LAPAROSCOPIC SURGICAL PROCEDURES FOR PEDIATRIC APPLICATIONS HAVE WITNESSED SLOWER ADOPTION
TABLE 57 MARKET FOR PEDIATRIC SURGERY, BY COUNTRY, 2019–2026 (USD MILLION)
8 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER (Page No. - 124)
8.1 INTRODUCTION
TABLE 58 MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF LAPAROSCOPIC INSTRUMENTS
TABLE 59 MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 INCREASING NUMBER OF CENTERS WILL DRIVE THE MARKET GROWTH
TABLE 60 MEDICARE REIMBURSEMENT RATES FOR LAPAROSCOPIC PROCEDURES FOR AMBULATORY SURGICAL CENTERS AND HOSPITALS IN 2021
TABLE 61 MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
9 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION (Page No. - 130)
9.1 INTRODUCTION
TABLE 62 MARKET, BY REGION, 2019–2026 (USD MILLION)
FIGURE 37 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH IN THE FORECAST PERIOD
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET
FIGURE 38 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT
TABLE 63 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 US
9.2.2.1 The US dominates the global laparoscopic instruments market
TABLE 68 US: KEY MACROINDICATORS
TABLE 69 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 70 US: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 US: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 72 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Unfavorable regulatory processes in Canada to restrain the market growth
TABLE 73 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN CANADA, 2015 VS. 2017
TABLE 74 CANADA: KEY MACROINDICATORS
TABLE 75 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 76 CANADA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 CANADA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 78 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET
TABLE 79 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 81 EUROPE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 EUROPE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 83 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to dominate the European market for laparoscopic instruments during the forecast period
TABLE 84 GERMANY: KEY MACROINDICATORS
TABLE 85 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 GERMANY: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 GERMANY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 88 GERMANY: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Favorable health insurance system to drive the market for laparoscopic instruments in France
TABLE 89 FRANCE: KEY MACROINDICATORS
TABLE 90 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 91 FRANCE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 FRANCE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 UK
9.3.4.1 Investments by hospitals in laparoscopy infrastructure to drive market growth in the UK
TABLE 94 UK: KEY MACROINDICATORS
TABLE 95 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 96 UK: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 UK: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 98 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Growing cancer incidence and the number of related diagnostic and therapeutic surgical procedures to drive market growth
TABLE 99 ITALY: KEY MACROINDICATORS
TABLE 100 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 101 ITALY: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ITALY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 103 ITALY: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Rising number of surgical procedures to drive market growth
TABLE 104 SPAIN: KEY MACROINDICATORS
TABLE 105 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 106 SPAIN: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 SPAIN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 108 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 109 LAPAROSCOPIC COLECTOMY, APPENDECTOMY, AND CHOLECYSTECTOMY PROCEDURES IN EUROPE, 2018 (PER 100,000 INHABITANTS)
TABLE 110 LAPAROSCOPIC HYSTERECTOMY SURGERIES IN EUROPE (2008 TO 2018)
TABLE 111 LAPAROSCOPIC REPAIR OF INGUINAL SURGERIES IN EUROPE (2013 TO 2018)
TABLE 112 ROE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 113 ROE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 ROE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 115 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET
FIGURE 39 APAC: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT
TABLE 116 APAC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 117 APAC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 APAC: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 APAC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 120 APAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Supportive reimbursement policies to drive market growth in Japan
TABLE 121 JAPAN: KEY MACROINDICATORS
TABLE 122 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China
TABLE 126 CHINA: KEY MACROINDICATORS
TABLE 127 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 CHINA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 CHINA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 130 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India
TABLE 131 INDIA: KEY MACROINDICATORS
TABLE 132 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 INDIA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 INDIA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 135 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.5 REST OF APAC
TABLE 136 ROAPAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 137 ROAPAC: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 ROAPAC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 139 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 140 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 141 LATIN AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 142 LATIN AMERICA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 LATIN AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 144 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil dominates the laparoscopic instruments market in Latin America
TABLE 145 BRAZIL: KEY MACROINDICATORS
TABLE 146 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 147 BRAZIL: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 BRAZIL: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 149 BRAZIL: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Increasing incidence of lifestyle-related disorders and increasing awareness drive market growth in Mexico
TABLE 150 MEXICO: KEY MACROINDICATORS
TABLE 151 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 152 MEXICO: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 MEXICO: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 154 MEXICO: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 155 ROLA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 156 ROLA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 ROLA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 158 ROLA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH
TABLE 159 MEA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 160 MEA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 MEA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 162 MEA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 187)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE LAPAROSCOPIC INSTRUMENTS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE, BY KEY PLAYER, 2020
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 42 MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 43 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
10.7 COMPANY PRODUCT FOOTPRINT
FIGURE 44 PRODUCT PORTFOLIO ANALYSIS: MARKET
10.8 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE MARKET
FIGURE 45 GEOGRAPHIC REVENUE MIX: MARKET (2020)
10.9 COMPETITIVE SCENARIO
TABLE 163 PRODUCT LAUNCHES (2017–FEBRUARY 2021)
TABLE 164 DEALS (2017–2020)
11 COMPANY PROFILES (Page No. - 199)
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, Strategic overview, SWOT Analysis, MNM view)*
11.1.1 INTUITIVE SURGICAL, INC.
TABLE 165 INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: INTUITIVE SURGICAL, INC. (2020)
11.1.2 ETHICON, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
TABLE 166 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: JOHNSON & JOHNSON (2020)
11.1.3 OLYMPUS CORPORATION
TABLE 167 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2020)
11.1.4 MEDTRONIC PLC
TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 49 COMPANY SNAPSHOT: MEDTRONIC PLC (2019)
11.1.5 STRYKER CORPORATION
TABLE 169 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: STRYKER CORPORATION (2019)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 170 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG (2019)
11.1.7 CONMED CORPORATION
TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: CONMED CORPORATION (2020)
11.1.8 BECTON, DICKINSON AND COMPANY
TABLE 172 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
11.1.9 SMITH & NEPHEW PLC
TABLE 173 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: SMITH & NEPHEW PLC (2020)
11.1.10 MICROLINE SURGICAL, INC. (A SUBSIDIARY OF HOYA CORPORATION)
TABLE 174 MICROLINE SURGICAL, INC.: BUSINESS OVERVIEW
FIGURE 55 HOYA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.11 KARL STORZ GMBH & CO.
TABLE 175 KARL STORZ GMBH & CO.: BUSINESS OVERVIEW
11.1.12 RICHARD WOLF GMBH
TABLE 176 RICHARD WOLF GMBH: BUSINESS OVERVIEW
11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED
TABLE 177 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
11.1.14 COOK MEDICAL INC.
TABLE 178 COOK MEDICAL INC.: BUSINESS OVERVIEW
11.1.15 SCHÖLLY FIBEROPTIC GMBH
TABLE 179 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 OPTOMIC
TABLE 180 OPTOMIC: BUSINESS OVERVIEW
11.2.2 VICTOR MEDICAL INSTRUMENTS CO., LTD.
TABLE 181 VICTOR MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
11.2.3 PETERS SURGICAL
TABLE 182 PETERS SURGICAL: BUSINESS OVERVIEW
11.2.4 ENDOMED SYSTEMS GMBH
TABLE 183 ENDOMED SYSTEMS GMBH: BUSINESS OVERVIEW
11.2.5 STRAUSS SURGICAL
TABLE 184 STRAUSS SURGICAL: BUSINESS OVERVIEW
11.2.6 AMNOTEC INTERNATIONAL MEDICAL
TABLE 185 AMNOTEC INTERNATIONAL MEDICAL: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, Strategic overview, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 251)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the laparoscopic instruments market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the laparoscopic instruments market was arrived at after data triangulation from four different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.
Objectives of the Study:
- To validate the segmentation defined through the assessment of the product portfolios of the leading players in the market
- To understand key industry trends and issues defining the growth objectives of market players
- To gather both demand- and supply-side validation of the key factors affecting market growth, including market drivers, restraints, opportunities, and challenges
- To validate assumptions for the market sizing and forecasting model used for this market study
- To understand the market positions of the leading players in the laparoscopic instruments market and their shares/rankings
- To understand the ongoing pricing trends in the market and future expectations
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific laparoscopic instruments market into South Korea, Australia, New Zealand, and others.
- Further breakdown of the Rest of Europe laparoscopic instruments market into Belgium, Russia, the Netherlands, Switzerland, and others.
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the top 3 companies
Generating Response ...
Growth opportunities and latent adjacency in Laparoscopic Instruments Market